bpc-157 fda news 2025 NBC | The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger-looking skin, Evidence out, ideology in. The

Evidence out, ideology in. The FDA's quiet peptide pivot has nothing to do with the data and everything to do with whose side the regulator is choosing. On April 15, 2026, the RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them

SKU: 20816629119 · From centoria.fr